|
Re: "57% relative risk reduction of MACE in patients with diabetes mellitus (DM) and CVD..."
|
5
|
Resverlogix Corp.
|
Aug 14, 2018 09:21AM
|
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
5
|
Resverlogix Corp.
|
Aug 14, 2018 11:04AM
|
|
ESC 2018 Symposium and Presentation August 25-29, Munich
|
7
|
Resverlogix Corp.
|
Aug 14, 2018 01:55PM
|
|
Re: Reverse Split, the good, bad and in between....
|
3
|
Resverlogix Corp.
|
Aug 15, 2018 08:08AM
|
|
Re: Reverse Split, the good, bad and in between....
|
9
|
Resverlogix Corp.
|
Aug 15, 2018 01:58PM
|
|
Re: ... time lines and yet to come...
|
7
|
Resverlogix Corp.
|
Aug 15, 2018 04:13PM
|
|
Re: time lines and yet to come...
|
6
|
Zenith Epigenetics
|
Aug 16, 2018 10:57AM
|
|
Re: time lines and yet to come...
|
3
|
Zenith Epigenetics
|
Aug 16, 2018 04:29PM
|
|
Re: ... time lines and yet to come...
|
5
|
Resverlogix Corp.
|
Aug 16, 2018 04:34PM
|
|
August 2018 Corporate Presentation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 21, 2018 12:16PM
|
|
Re: August 2018 Corporate Presentation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 21, 2018 01:00PM
|
|
Re: Many hands make light work....
|
3
|
Resverlogix Corp.
|
Aug 22, 2018 06:58AM
|
|
Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presentation on Apabetalone at the European Society of Cardiology Congress 2018
|
3
|
Resverlogix Corp.
|
Aug 22, 2018 07:08AM
|
|
Re: Many hands make light work....
|
4
|
Resverlogix Corp.
|
Aug 22, 2018 07:25AM
|
|
Crossing the blood-brain barrier: Bioasis Technologies lead the way with their xB3 technology platform
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 22, 2018 02:19PM
|
|
Re: Not predicting another short attack....
|
8
|
Resverlogix Corp.
|
Aug 23, 2018 02:15PM
|
|
Clinical Steering Committee meeting for BETonMACE?
|
5
|
Resverlogix Corp.
|
Aug 24, 2018 09:54AM
|
|
New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
7
|
Resverlogix Corp.
|
Aug 24, 2018 10:08AM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Aug 24, 2018 10:15AM
|
|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
7
|
Resverlogix Corp.
|
Aug 24, 2018 03:33PM
|
